2 stories mentioning EDITUpdated 59m ago
Every FINWIRES story that references EDIT, newest first.
Editas Medicine (EDIT) has an average rating of overweight and mean price target of $6, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Editas Medicine (EDIT) said Tuesday it has priced an underwritten public offering of 55.6 million common shares and accompanying warrants at a combined public offering price of $2.25 per share and warrant.Gross proceeds are estimated to be about $125 million. The company. said it could receive an additional $194.4 million if all accompanying warrants are exercised, bringing the potential gross proceeds to about $319.4 million.The offering is expected to close around Wednesday, subject to customary closing conditions.Price: $2.82, Change: $+0.06, Percent Change: +1.99%
